Where does Verrica Pharmaceuticals Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Verrica Pharmaceuticals Inc. ranks #27,769 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Verrica Pharmaceuticals Inc. hold?

Verrica Pharmaceuticals Inc. holds 10 US utility patents granted between 2020 and 2025, spanning 8 technology areas.

What is Verrica Pharmaceuticals Inc.'s Innovation Score?

Verrica Pharmaceuticals Inc. has an Innovation Score of 31.5 out of 100 (38th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Verrica Pharmaceuticals Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Verrica Pharmaceuticals Inc..

What does claim depth mean for Verrica Pharmaceuticals Inc.'s patents?

Verrica Pharmaceuticals Inc.'s patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Verrica Pharmaceuticals Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Verrica Pharmaceuticals Inc.

Q: What technology areas does Verrica Pharmaceuticals Inc. focus on?

Verrica Pharmaceuticals Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Verrica ranks #27,769 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.

#27,769
of 49,997 US assignees by volume: 38th percentile
by Innovation Score (31.5/100): 17.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R27769 · US Corporation #27,769 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #27,769/49,997
PHOTO-FINISH Verasonics
CPC-NARROW A61P · 8 areas
INNOV-THIN 31.5/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Verasonics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Verrica Pharmaceutic… · this assignee

32
3D Lighting… · lowest

7

What this shows Verrica's Innovation Score is 31.5/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Verrica's grants concentrate

Verrica Pharmaceuticals Inc. is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2023. By volume, Verrica sits between Verasonics, Inc. and Via Fortuna, LLC.

Verrica's three-year grant acceleration

Verrica Pharmaceuticals Inc. shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Verasonics

10
Verbit Software

10
Verco Materials

10
Verno Holdings

10
Versare Solutions

10
Vesatek

10
Veyes

10
Via Fortuna

10
Verrica Pharmaceu… ◀

10

What this shows Verrica holds 10 patents at rank #27,774, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Verrica

By rank, the assignees closest to #27,774 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Verrica's primary technology class.

Verrica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 38th percentile higher than 38% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Verrica Pharmaceuticals Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	20.0%
2021	3	30.0%
2023	1	10.0%
2024	1	10.0%
2025partial year	3	30.0%

Which technologies does Verrica Pharmaceuticals Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07D - Heterocyclic Compounds 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#27,769

of 49,997 tracked assignees

Innovation Score

31.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Verrica Pharmaceuticals Inc.'s patent record in context - here's where to go next.

Verrica Pharmaceuticals Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 60% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #27,769 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Verrica Pharmaceuticals Inc. against Verasonics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.